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Abstract
DNA-based microarrays are increasingly central to biomedical research. Selecting oligonucleotide sequences that will
behave consistently across experiments is essential to the design, production and performance of DNA microarrays. Here
our aim was to improve on probe design parameters by empirically and systematically evaluating probe performance in a
multivariate context. We used experimental data from 19 array CGH hybridizations to assess the probe performance of
385,474 probes tiled in the Duchenne muscular dystrophy (DMD) region of the X chromosome. Our results demonstrate that
probe melting temperature, single nucleotide polymorphisms (SNPs), and homocytosine motifs all have a strong effect on
probe behavior. These findings, when incorporated into future microarray probe selection algorithms, may improve
microarray performance for a wide variety of applications.
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Introduction
DNA-based microarrays have become central to current
biomedical research for a host of diverse applications[1], ranging
from assessment of genomic copy number (array CGH)[2,3,4] and
identification of transcription binding sites (ChIP-chip)[5,6,7] to
resequencing[8,9,10,11,12] and SNP genotyping[13,14,15,16,17].
Of great excitement is a recent application, microarray-based
genomic selection (MGS), which can serve as a bridge to next-
generation resequencing technologies, enabling the complete
ascertainment of sequence variation in large, specific regions of
the human genome[18,19,20]. Appropriate microarray design is
fundamental to the success of these experiments.
To optimize the design, production, and performance of DNA
microarrays, selecting the right oligonucleotide sequences to be tiled
is essential. Probes should be chosen to maximize the information
contributed by every available feature on an array. What constitutes
‘‘information’’ on a DNA microarray is largely the effective binding
of a probe to its target sequence, in the absence of cross-
hybridization of non-target sequence; this is a universally desirable
property, regardless of the microarray application. There are
numerous algorithms based on variouscriteria to aidin the selection
of probe sequences. Bertone and colleagues focused on optimizing
methods for choosing probes in a genomic region heterogeneous for
repetitive and unique elements, with the aim of maximizing the
percentage of non-repeat bases covered[21]. Graf and coworkers
expanded on these results by developing a probe uniqueness score
(U) based on the number of unique substrings of sequence within a
given target region[22]. This group developed a probe-selecting
algorithmincorporatingU,meltingtemperature(Tm),and synthesis
cycle numberwith sequence-specificfilters.With this algorithm they
have demonstrated acceptable coverage of the mouse genome[22].
Array manufacturers have used similar methods to create
proprietary, platform-specific algorithms for array design. For
example, Roche NimbleGen (Madison, WI) combines synthesis
cycles (with a sliding upper limit depending on final probe length),
Tm, repetitive element exclusion, and uniqueness measures to select
probes[23]. Nonetheless, the probes selected by all these algorithms
have yet to be evaluated experimentally. Moreover, such direct
empirical evaluation of probe performance would drive better
design algorithms.
There has been some empirical characterization of probe
behavior by various groups. Sharp et al. characterized the
performance of Roche NimbleGen probes in detail using an array
CGH format. Seven individuals with a validated genomic
imbalance on chromosome 15q, where each individual has from
one to six copies of the same locus, were assessed on a custom-
designed array with 91,069 probes available to detect copy
number[24]. The outcome measure was the Pearson’s correlation
coefficient for a given probe (r) between normalized log(2) ratio
values and copy number across experiments. This group found
that probe uniqueness, SNP content, probe length, Tm, and
guanine homopolymers all influenced probe performance[24].
The negative influence of guanine- or purine-rich sequence has
been noted by other groups[25,26]. However, all the variables
considered by Sharp et al. were examined individually, without a
multivariate analysis that could enable detection of correlated
variance components. An additional univariate study found probe
uniqueness and homopolymer presence (. length 5), but not
probe length or Tm, to affect the resolving power of array CGH to
detect deletions in both human and C. elegans experiments[27]. As
with Sharp et al., a multivariate analysis was not performed.
We sought to refine probe design parameters by evaluating
probe performance in a multivariate context empirically and
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since this format is both the most amenable to custom design and
currently has the highest probe densities. In most analysis
techniques, data for a given probe is the log(2) ratio of signal
intensity between two samples. We reasoned that well-behaved
probes ought to give consistent log(2) ratios near 0, whereas poorly
behaved probes will vary around 0 more widely. Therefore we
elected to focus on the variance in the log(2) ratios across multiple
experiments as a measure of poor probe behavior. We believe this
measure simultaneously identifies probes with both unreliable
binding by target sequences as well as low target capture, since low
signal often inflates the log(2) variance. We used experimental data
from 19 array CGH hybridizations to evaluate probe performance
for 385,474 probes tiled in the Duchenne muscular dystrophy (DMD)
region of the X chromosome. We used as predictor variables
several sequence-derived probe characteristics, including Tm,
probe length, probe GC content, probe purine content, and the
presence of a known SNP in the probe. We also explored whether
the presence and length of homoadenine, homocytosine, homo-
guanine, or homothymidine sequence motifs could influence probe
performance. The outcome measure, variance in normalized
log(2) ratios across experiments, was dichotomized based on the
observed distribution of values across probes. Following univariate
analysis, we incorporated multiple predictor variables into
hierarchical models to reveal the subset of predictor variables
with the effects on probe performance. Our results indicate that
Tm, the presence of a SNP, and the presence of homocytosine
motifs all influence probe behavior. These data should improve
array design substantially by refining the algorithms to optimize
probe performance.
Results
Examining the distribution of variance revealed that the
majority of probes have low variance (,0.1, n=378,057), with
only ,2% of probes showing high variance (.0.1 and ,4.97,
n=7,417). We dichotomized the probes based on a cutoff of 0.1
(Figure 1, and see Figure 2 for raw data examples). Results of our
univariate analysis are described in Tables 1, 2 and 3. Variables
that were found to be highly significant (p,0.01) included Tm,
probe length, GC content, presence of a SNP, average
heterozygosity of a SNP, polyA, polyC, polyG, and polyT. Low-
variance probes had a higher Tm, shorter length, higher GC
content, shorter polyA or polyT runs, and longer polyC or polyG
runs. Low-variance probes were also less likely to have a SNP.
Among those probes that did have a SNP, low-variance probes
have less common (i.e., lower frequency) SNPs. Purine content was
not associated with probe performance.
Tm, probe length, and GC content all appear to be related to
one another. To examine the degree of relationship, we computed
Pearson’s correlations among these variables. This revealed a
highly correlated structure among these three variables (Table 4).
To discern which variable(s) were having the primary effect on
probe performance, we compared Akaike’s information criterion
(AIC) from single-term models, where probe performance was
regressed on length, GC content, or Tm (Table 5). Based on the
AIC, Tm is the predictor that best fits the data. We then compared
two-term models with Tm and either length or GC content to
assess whether there were residual effects of these variables after
accounting for Tm. When either length or GC content is included
in a model with Tm, neither length nor GC content is a significant
Figure 1. Observed variance in probe performance across multiple array CGH experiments. 384,475 probes are ranked by variance in
normalized log(2) ratios across 19 array CGH experiments. Rank order of probe is plotted on the x-axis, variance on the y-axis. A dotted horizontal line
is drawn at variance =0.1, where probes are dichotomized according to ‘‘low’’ or ‘‘high’’ variance. Inset: number of probes that fall into each category.
doi:10.1371/journal.pone.0009921.g001
Probe Selection
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values, using Tm alone is the most parsimonious model that fits
the data best (Table 6). This implies either that Tm is the primary
factor among these variables contributing to probe performance,
or that our Tm calculation effectively describes length and/or GC
content.
We then examined the potential association of the remaining
significant variables (polyA, polyT, polyG, polyC, presence of a
SNP) with probe performance by adding these terms to a model
including Tm. The AIC of each model shows that the presence of
a SNP and polyC are independently predictive of probe
performance, but the remaining variables (polyA, polyT, polyG)
do not have a significant relationship to probe performance after
adjusting for Tm (Table 7). The presence of a SNP is significantly
associated with poor probe performance, whereas the presence of
poly-cytosine motifs are predictive of good probe performance,
after adjusting for Tm effects. The majority of this latter effect is
contributed by the tricytosine motif, with a minority contributed
by a quadcytosine motif. Five or more cytosines in a row appear to
have no effect on probe performance (Table 8), although this is
likely a reflection of the small number of such observations.
Discussion
We reasoned that the log(2) ratio from a given probe in an array
CGH experiment is a useful proxy for the information yielded by
that probe. We propose that the variance in the log(2) ratio across
multiple experiments captures poor probe behavior, such as
unreliable binding by target sequences as well as low target
capture, since at low signals the log(2) variance is often inflated.
We explored other measures of probe performance from our array
CGH data, including raw intensity measures for Cy3 (532
channel) and Cy 5 (635 channel) both separately and combined,
and the ratio of the standard deviation to the mean intensity across
experiments for Cy3, Cy5, and combined intensities. These
measures all yielded very similar distributions, with most probes
behaving in a consistent fashion, but with ,2% of probes giving
highly unreliable data. This implies that we have identified a true
set of poorly performing probes.
Using this definition of poorly performing probes, our study
demonstrates that Tm, homocytosine motifs, and the presence of a
SNP are all significant predictors of probe performance in
microarray design. Tm is a highly significant predictor: an
increase in Tm of ten degrees renders a probe almost three times
Figure 2. Examples of data from low- and high-variance probes. Normalized log(2) ratio data for 5 probes of low variance and 5 probes of
high variance across multiple experiments. High-variance probes are likely to have outlier values for one or more experiments, but also have large
variance even when outliers are excluded.
doi:10.1371/journal.pone.0009921.g002







Tm 65.13 63.87 ,2.2e-16
Length 56.55 56.97 ,2.2e-16
GC content (%) 35.93 33.28 ,2.2e-16
Purine content (%) 50.47 50.56 0.4538
Proportion with SNP 0.141 0.158 .000011
SNP heterozygosity 0.144 0.157 0.032
doi:10.1371/journal.pone.0009921.t001
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category. The next largest predictor of probe performance is
presence of a SNP. After adjusting for Tm, we find there is a 15%
increase in the likelihood that a probe will be in the high-variance
(i.e., lower reliability) category if it contains a known SNP. Further,
we find that homocytosine motifs of size 3 or greater are associated
with reliable probe performance.
The array we used is specific to the DMD region of the X
chromosome. An advantage to this experimental design is that
patient samples are unlikely to have additional copy number
variants, aside from the pathological deletions and duplications
already identified and excluded prior to this analysis. This is
important, because if there were additional deletions or duplica-
tions, the variance of the log(2) ratio data would be artificially
inflated, and we would run the risk of misclassifying probes,
leading our analysis astray.
Our analysis identifies poorly behaving probes as those that do
not behave reliably across multiple experiments. There is another
potential class of poorly performing probes: those that have
saturated intensity due to signal from cross-hybridization of non-
unique sequence. These probes might behave consistently from
experiment to experiment, qualifying as well-behaved according to
our criteria. However, because potential probes are first screened
for non-unique sequence, and probes with too many genomic
matches discarded, this is likely a small source of misclassification.
Ultimately, our results are in predominant agreement with other
analyses, in particular those of Sharp et al. As in previous reports,
we find SNP content and Tm to be significant predictors of poorly
performing probes. However, because our analysis could be
extended to a multivariate format, we were able to test directly
among the related variables Tm, GC content, and probe length to
arrive at the predictor variable(s) with the largest effect(s). While
Sharp et al. attempted to correct for relationships among predictor
variables, they did so in an indirect manner, measuring covariance
between variables, and their analysis framework did not allow
simultaneous adjustment for multiple predictor variables. Further-
more, Sharp et al. used an approximation for Tm that did not take
into account the microarray environment. The Tm calculation we
have used is one most appropriate for surface-bound oligonucle-
otides, and may more accurately estimate the true melting
temperature of the oligos. Nevertheless, it should be noted that
the Sharp et al array was specific to a single region of the genome,
on chromosome 15. It is possible that their results are specific to
this single genomic interval and may not be generalized across the
genome, which perhaps accounts for the minor differences
between our results and those of previously published studies.
There are likely two dimensions to probe performance: the
ability of a probe to be correctly synthesized on an array, and the
ability of a correctly synthesized probe to bind its target. The
variables found to have the strongest effects in this analysis, Tm
and presence of a SNP, are likely related to hybridization and not
synthesis; however, the contribution of the tricytosine and
quadcytosine motifs to probe performance remains unclear. It is
possible that three or four cytosines in a row allow a probe to
assume a three-dimensional conformation that renders it highly
available to its target sequence. It is also possible that, once a target
sequence binds to a probe with more than three cytosines, it is
stably bound due to the large number of hydrogen bonds holding
it in place. Another possibility is that during synthesis, cytosines
have a slightly higher coupling efficiency than the three other
nucleotides, and therefore three or more cytosines in a row are the
motifs likely to have the fewest base misincorporations during
array manufacture.
Sharp et al. have shown an excess of polyG motifs in poorly
performing probes on Roche NimbleGen arrays, the same
technology used in our study[24]. A second group has previously
shown that on Affymetrix resequencing arrays, purine-rich (and
specifically guanine-rich) probes are overrepresented among probe
failures[24,25]. Our analysis fails to discern any relationship
between purine-rich sequences or polyG motifs and poor probe
performance. Results from our univariate analysis imply that there
is an overabundance of polyG motifs in low-variance (or ‘‘good’’)
probes. However, when we incorporate Tm and polyG motifs in a
model together, there is no significant effect from the polyG
motifs. It is therefore possible that prior reports of polyG sequences
associated with poor probe performance actually reflect a Tm
relationship. In fact, Sharp et al. show that polyG is positively
correlated with Tm, but speculate that polyG motifs have an effect
independent of Tm[24]. They do not show this directly, however,
Table 2. Percent of low and high variance probes with homopolymer runs (nucleotide, variance).
Size of Homopolymer A, Low A, High T, Low T, High C, Low C, High G, Low G, High
1o r2 21.3 18.0 23.8 20.6 73.7 80.1 74.0 77.5
3 37.3 37.8 38.0 37.9 23.1 18.0 22.8 20.2
4 27.8 30.3 26.2 28.4 3.2 1.9 3.2 2.3
5 11.5 12.2 10.3 11.8 na na na na
6 1.8 1.5 1.5 1.0 na na na na
7 0.3 0.2 0.3 0.3 na na na na
doi:10.1371/journal.pone.0009921.t002
Table 3. Results of univariate analysis, categorical variables.
ACGT
chi-square 62.79 69.70 160.97 51.36
p-value 3.213e-12 1.182e-13 ,2.2e-16 7.021e-12
doi:10.1371/journal.pone.0009921.t003
Table 4. Pearson’s correlations between predictor variables
(all p ,2.2e-16).
Tm Length
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analysis framework. Furthermore, Zwick et al. and Cutler et al.
also do not test for Tm[25,26]. It therefore remains possible that
the polyG relationship really reflects a Tm relationship best
accounted for when we include Tm in a multivariate analysis. It is
also possible that polyG has different effects depending on the
genomic region being examined (or on the organism, as Zwick et
al. were sequencing Bacillus anthracis). The genomic region on
15q11 tested by Sharp et al. is 41% GC, compared with 36.3%
GC in the DMD region we tested in our study, suggesting that GC
content alone is not responsible for this discrepancy. Alternatively,
it is possible that manufacturers have already responded to known
purine (or guanine) issues by improving their synthesis chemistries
in the interval between the two studies.
Our analysis here examines probes already selected by the
manufacturer’s algorithm. Such algorithms actually work well, as
evidenced by the fact that fewer than 2% of the probes on our
array had high variance across experiments. However, the analysis
we present here allows for a quantifiable estimate attached to each
predictor variable, providing some much-needed guidance when
selecting probes for custom-designed arrays. For example,
although it was already known that both Tm and SNP are
important, our analysis implies that low Tm is ‘‘worse’’ than the
presence of a SNP in a probe. We propose a sequential series of
considerations when designing probes that could significantly
reduce probe failure (Figure 3). Such enhanced probe selection,
however modest, could still have a major experimental impact
(Figure S1). As microarray probe density continues to increase, a
2% probe failure rate represents a substantial cost in data loss. By
way of illustration, with Roche NimbleGen’s latest high-density
array of 2.1 million probes, a 2% rate translates to the failure of
42,000 probes. What this means for array CGH is that such losses
could obscure copy number discrimination or reduce precision in
breakpoint determination. For MGS, critical genomic regions
targeted for capture and resequencing may be missed. Thus we
propose that the data reported here will help reduce probe failure




We obtained 19 de-identified patient DNA samples with
previously characterized DMD gene structural mutations (deletions
and duplications) from the Emory Genetics Laboratory, OHSU
DNA Diagnostic Laboratory, and LabPLUS, Auckland, New
Zealand. All samples were stripped of personal identifiers and
numbered randomly. This study was approved by the Emory
University Institutional Review Board (#IRB00024817).
All patients had prior clinical validation of DMD structural
mutations identified by multiplex PCR of 32 exons and/or
Southern blot. We evaluated DNA from these patients with array
CGH using a custom-designed array with 385,474 probes in the
dystrophin gene region, which spans 2,222,000 bases on chromo-
some X (31,046,000–33,268,000; www.ucsc.edu). The vast
number of probes permits oversampling of the region; the average
spacing between probe starts is less than six bases. The array used
in these experiments was designed and manufactured by Roche
NimbleGen Systems, Inc. (Madison, WI). Roche NimbleGen used
in-house design criteria to select probes. These design criteria
included four main components: (1) an upper limit on synthesis
cycles, (2) probe selection based on Tm, (3) avoidance of repetitive
elements, and (4) a proprietary ‘‘uniqueness measure’’[23].
DNA extraction was performed on patient DNA using the
Gentra Systems Puregene DNA extraction kit according to the
manufacturer’s instructions. Normal male and female reference
DNA was obtained from Promega, Inc. Each patient and reference
DNA sample was sonicated such that fragment size was between
500–2000 bases, as verified on a 1% agarose gel. Patient and
reference DNA samples were then labeled using Klenow enzyme
(NEB) and Cy3 or Cy5 9 mer wobble primers (TriLink Technol-
ogies), respectively. After labeling, each sample was purified by
isopropanol precipitation and reconstituted in ultra-pure water. We
combined 13 ug each of labeled patient and reference DNA, and
Table 5. Comparison of single-term models with Tm, GC






Table 6. Testing for residual effects of GC content or probe
length, after adjusting for Tm.
Model Includes Estimates beta se p-value Model AIC
Tm Tm 20.111 0.003 ,2e-16 72273
Tm + GC content Tm 20.108 0.014 8.89e-15 72275
GC content 20.002 0.006 0.794
Tm + length Tm 20.113 0.003 ,2e-16 72273
Length 20.005 0.003 0.126
doi:10.1371/journal.pone.0009921.t006
Table 7. Comparison of models with remaining predictor
variables.






PolyC + SNP 72236
doi:10.1371/journal.pone.0009921.t007
Table 8. Final model including Tm, SNP, and polyC.
Variable beta se p-value Final Model AIC
Tm 20.107 0.004 ,2e-16 72236
SNP 0.143 0.032 8.32e-06
Poly C (3) 20.134 0.031 1.81e-05
Poly C (4) 20.204 0.087 0.0185
PolyC (5) 29.15 54.5 0.8667
doi:10.1371/journal.pone.0009921.t008
Probe Selection
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resuspended in appropriate hybridization buffer along with Cy3
and Cy5 control CPK6 50 mer oligonucleotides. This mixture was
hybridized to the array for 16–20 h at 42uC in a Maui
Hybridization instrument (BioMicro Systems). Arrays were then
washed according to the manufacturer’s recommendation and
immediately scanned on a GenePix 4000 scanner (Molecular
Devices).Afterscanning, intensity data wereextracted from images,
and within-array normalization was accomplished using manufac-
turer-provided software (NimbleScan). Normalized log(2) ratio data
were analyzed using the GLAD[28] program as implemented in R.
Predictor variables
Characteristics we hypothesized might be related to probe
performance were: probe melting temperature (Tm), probe length,
probe GC content, probe purine (AG) content, the presence/
absence and average heterozygosity of a known SNP, maximum
size homoadenosine sequence, maximum size homocytosine
sequence, maximum homoguanine sequence, and maximum
homothymidine sequence in a probe. These variables were
derived from the probe sequence via a custom Perl program.
Tm was calculated using the thermodynamic model proposed
by Vainrub and Pettitt[29], which modifies the Langmuir isotherm
to appropriately account for electrostatic interactions among
surface-bound molecules, which are present in microarray
environments, as follows:
Tm~DH0zNpwL2




Briefly, let DH0 be the probe reference state enthalpy, DS0 the
probe reference state entropy, Np the probe density, w the
interaction strength constant, L the probe length, R the universal
gas constant, S the feature size surface area, V the hybridization
volume, and NA Avogadro’s number. Entropy, enthalpy, and
initiation parameter values for calculating DH0 and DS0 were
obtained from the unified nearest-neighbor thermodynamic
method proposed by SantaLucia[30]. We assumed values of
50,000 per square micron for Np,4 610
216 for w,2 0 624 uM for
S, and 2.0e-4 for V. All values are approximately consistent with
our experimental conditions. Tm was calculated according to the
formula above from the sequence composition of each probe, as
implemented in a custom Perl program.
Probe length was calculated based on the probe sequence
(range: 50 to 75 nucleotides). GC content and purine content were
expressed as proportions. The presence of a known SNP was
assessed by obtaining all known SNP positions cataloged in dbSNP
(build 128) within the 2.22-Mb DMD region on chromosome X
(n=6883). We asked whether any SNPs mapped within the
interval defined by the probe start and stop positions for all probes
on the array; probes with SNPs were coded as ‘‘1’’, and those
without were coded as ‘‘0’’. For probes with SNPs, we recorded
the type of SNP and, when available, the average heterozygosity.
For the maximum homonucleotide sequence within a probe, we
recorded the longest stretch of homonucleotides .2 for all four
possible nucleotides (A,G,C,T; four different variables for each
probe: polyA, polyC, polyG, polyT). Probes with a maximum 1 or
2 of any homo[A,G,C,T] sequence were coded as ‘‘0’’, probes with
3 homo[A,G,C,T] were coded ‘‘1’’, probes with 4 homo[A,G,C,T]
were coded ‘‘2’’, and so on. When tabulating the data, we noticed
Figure 3. Proposed algorithm to refine probe selection.
doi:10.1371/journal.pone.0009921.g003
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G) there were cells with n,5. Small numbers in any one cell of a
table can inflate a chi-square test, but our sample size renders
Fisher’s exact test computationally intractable. As a compromise,
we chose to collapse the highest categories downward, until all
cells had a minimum value of 5, as follows: for A and T, probes
with runs 7 or greater (maximum run size =9 for A, 8 for T) were
collapsed into a single group (number of recoded probes =138 for
A, n=89 for T); for G and C, probes with runs 4 or greater
(maximum run size =6 for C, 8 for G) were collapsed into a single
group (number of recoded probes =96 for C, n=175 for G).
Outcome variable
For each array, we excluded probes within the DMD region that
were known to be deleted or duplicated for each patient; we kept
probe data only for regions with equal genomic content between
test and reference. To avoid unfairly inflating the variance in
probes because of uncertainty in the predicted breakpoints of
known copy number variants, we also excluded probes within
25 kb of a predicted breakpoint. For all 385,474 probes, we
calculated the variance of the normalized log(2) ratio across all
experiments (range 0.0018–4.97). Examining the distribution of
variance revealed that the majority of probes have low variance
(,0.1, n=378,057), with only a fraction of probes displaying high
variance (.0.1 and ,4.97, n=7417). We dichotomized the
probes based on a 0.1 variance cutoff.
Forunivariate analysis, wecompared thedistributionof predictor
variables between low- and high-variance probes using Student’s t-
test for continuous variables and a chi-square test for categorical
variables. To examine bivariate relationships among Tm, GC
content, and probe length, we computed Pearson’s correlations
among these variables. After univariate exploration of the data,
variables with significant differences (p,0.05) between low- and
high-variance probes were investigated further in multivariate
analysis using a logistic regression model. To best capture the
nonlinear relationship between homonucleotide runs and probe
performance, dummy categorical variables were created. Dummy
categorical variables were also created for Tm, in 5-degree bins, to
confirm that the Tm-probe performance relationship was linear
acrosstheTm range (datanotshown).Modelswerecompared using
Akaike’s information criterion (AIC)[31].
Supporting Information
Figure S1 Effect of Removing Bad Probes. Array CGH data for
5 samples. Normalized log(2) ratio plotted by position. Top panel
includes data for all probes. Bottom panel includes data for 98% of
the data (excludes 2% of probes with excessive variance).
Found at: doi:10.1371/journal.pone.0009921.s001 (0.23 MB
PDF)
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